Dr. Patrick F. Reilly, MD
Gastroenterology (Gastroenterology Physician)
- Medicare participating
At a glance
- Medical school
- University of South Alabama College of Medicine (1998)
- Years since graduation
- 28
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 647
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1998Medical school: University of South Alabama College of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Gastroenterology Physician primary
FL license ME0090180
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Sacred Heart Hospital Pensacola, FL
- Baptist Hospital Pensacola, FL
- Centura Health-St Anthony North Health Campus Westminster, CO
- Gulf Breeze Hospital Gulf Breeze, FL
- The East Alabama Healthcare Authority Opelika, AL
Medical groups
- The East Alabama Health Care Authority (120 clinicians)
- Gastroenterology Associates of Pensacola PA (41 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 647
- Services billed
- 9,447
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Injection, vedolizumab, 1 mg | 6,000 | 12 |
| Injection, infliximab, excludes biosimilar, 10 mg | 1,060 | 11 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 193 | 191 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 125 | 63 |
| Biopsy of large bowel using a flexible endoscope | 124 | 123 |
| Established patient office or other outpatient visit, 30-39 minutes | 122 | 94 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 101 | 101 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 61 | 59 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 54 | 53 |
| Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 53 | 53 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Pantoprazole Sodium Other prescribers in Pensacola, FL | 151 |
| Omeprazole Other prescribers in Pensacola, FL | 132 |
| Promethazine Hcl Other prescribers in Pensacola, FL | 90 |
| Esomeprazole Magnesium Other prescribers in Pensacola, FL | 62 |
| Famotidine Other prescribers in Pensacola, FL | 43 |
| Dextrose In Lactated Ringers (dextrose 5%-lactated ringers) | 34 |
| Metoclopramide Hcl Other prescribers in Pensacola, FL | 33 |
| Dicyclomine Hcl Other prescribers in Pensacola, FL | 29 |
| Stelara (ustekinumab) | 29 |
| Diphenoxylate-Atropine (diphenoxylate hcl/atropine) Other prescribers in Pensacola, FL | 27 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 10 companies reported 32 payments worth $623 in total to this clinician.
| AbbVie Inc. | $144 |
|---|---|
| Regeneron Healthcare Solutions, Inc. | $115 |
| Madrigal Pharmaceuticals | $74.26 |
| Janssen Biotech, Inc. | $66.79 |
| Pfizer Inc. | $60.84 |
| Lilly USA, LLC | $54.45 |
| Genzyme Corporation | $44.45 |
| Takeda Pharmaceuticals U.S.A., Inc. | $36.98 |
| Food and Beverage | $623 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.